Dr. Nardos Temesgen, MD

Dr. Temesgen practices at Cedar Hill Regional Medical Center in Washington, District of Columbia.

Dr. Temesgen's NPI, 1508250424, was assigned on March 28, 2015. Dr. Temesgen graduated from Wright State University Boonshoft School of Medicine in 2015. Dr. Temesgen holds District of Columbia license MD046002.

Dr. Temesgen's primary practice is Cedar Hill Regional Medical Center, at 1200 Pecan St Se, Washington, DC 20032 in District Of Columbia County. The practice phone is (804) 237-7129.

Dr. Temesgen's primary practice is Cedar Hill Regional Medical Center in Washington, District of Columbia. Dr. Temesgen is also affiliated with The George Washington University Hospital. The medical group on file is The GW Medical Faculty Associates. Dmand AI also links Dr. Temesgen to 2 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Temesgen practices. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Temesgen's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Temesgen is licensed in District of Columbia.

CMS data shows 289 Medicare services from Dr. Temesgen across 9 procedure codes in 2024, for 190 Medicare patients. Medicare paid $34,357 for them.

CMS counts 190 Medicare patients who saw Dr. Temesgen in 2024. The largest group is 65 to 74, with 76 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 17% are also on Medicaid. Their average risk score is 2.53, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Temesgen's median patient age at 70, with 49% women.

In 2024, Dr. Temesgen wrote 643 Medicare Part D claims for 74 patients. 81% of them were for generic drugs. CMS names the drug for 559 of them, across 17 drugs with 11 or more claims each, at $121,007 in total drug cost. In 2023, CMS named 210 claims across 10 drugs.

Dr. Temesgen accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Coronary angioplasty and stenting: 1 to 10 procedures (CMS shows small counts as a range)

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 4 papers to Dr. Temesgen, published from 2018 to 2020. 2018 was the busiest year, with 2. The most frequent topics are Electronic Nicotine Delivery Systems, Myocardial Infarction and Vaping. Dr. Temesgen has published most often in Am J Prev Med. Dr. Temesgen's most frequent co-authors are Ivan Pena, MD, Jalil E. Ahari, MD and Padma A. Shenoy, MD.

CMS Open Payments shows 158 general payments to Dr. Temesgen from 27 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 70% of the total. Medtronic, Inc. paid the most, $4,295.

Dr. Temesgen graduated from Wright State University Boonshoft School of Medicine in 2015.